1. AndrewsNC (2008) Forging a field: the golden age of iron biology. Blood 112: 219–230.
2. WallanderML, LeiboldEA, EisensteinRS (2006) Molecular control of vertebrate iron homeostasis by iron regulatory proteins. Biochimica et Biophysica Acta 1763: 668–689.
3. McKieAT, MarcianiP, RolfsA, BrennanK, WehrK, et al. (2000) A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Molecular Cell 5: 299–309.
4. DonovanA, LimaCA, PinkusJL, PinkusGS, ZonLI, et al. (2005) The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metabolism 1: 191–200.
5. AbboudS, HaileDJ (2000) A novel mammalian iron-regulated protein involved in intracellular iron metabolism. Journal of Biological Chemistry 275: 19906–19912.
6. GanzT, NemethE (2011) Hepcidin and disorders of iron metabolism. Annual Review of Medicine 62: 347–360.
7. ZhangDL, SenecalT, GhoshMC, Ollivierre-WilsonH, TuT, et al. (2011) Hepcidin regulates ferroportin expression and intracellular iron homeostasis of erythroblasts. Blood 118: 2868–2877.
8. DelabyC, PilardN, PuyH, Canonne-HergauxF (2008) Sequential regulation of ferroportin expression after erythrophagocytosis in murine macrophages: early mRNA induction by haem, followed by iron-dependent protein expression. The Biochemical journal 411: 123–131.
9. MarroS, ChiabrandoD, MessanaE, StolteJ, TurcoE, et al. (2010) Heme controls ferroportin1 (FPN1) transcription involving Bach1, Nrf2 and a MARE/ARE sequence motif at position -7007 of the FPN1 promoter. Haematologica 95: 1261–1268.
10. HentzeMW, MuckenthalerMU, AndrewsNC (2004) Balancing acts: molecular control of mammalian iron metabolism. Cell 117: 285–297.
11. MuckenthalerMU, GalyB, HentzeMW (2008) Systemic iron homeostasis and the iron-responsive element/iron-regulatory protein (IRE/IRP) regulatory network. Annual Review of Nutrition 28: 197–213.
12. LymboussakiA, PignattiE, MontosiG, GarutiC, HaileDJ, et al. (2003) The role of the iron responsive element in the control of ferroportin1/IREG1/MTP1 gene expression. Journal of Hepatology 39: 710–715.
13. De DomenicoI, WardDM, LangelierC, VaughnMB, NemethE, et al. (2007) The molecular mechanism of hepcidin-mediated ferroportin down-regulation. Molecular Biology of the Cell 18: 2569–2578.
14. NemethE, TuttleMS, PowelsonJ, VaughnMB, DonovanA, et al. (2004) Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306: 2090–2093.
15. FernandesA, PrezaGC, PhungY, De DomenicoI, KaplanJ, et al. (2009) The molecular basis of hepcidin-resistant hereditary hemochromatosis. Blood 114: 437–443.
16. LeePL, BeutlerE (2009) Regulation of hepcidin and iron-overload disease. Annual review of pathology 4: 489–515.
17. DrakesmithH, SchimanskiLM, OrmerodE, Merryweather-ClarkeAT, ViprakasitV, et al. (2005) Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin. Blood 106: 1092–1097.
18. ShamRL, PhatakPD, NemethE, GanzT (2009) Hereditary hemochromatosis due to resistance to hepcidin: high hepcidin concentrations in a family with C326S ferroportin mutation. Blood 114: 493–494.
19. BartonJC (2007) Chelation therapy for iron overload. Current gastroenterology reports 9: 74–82.
20. TheilEC, EisensteinRS (2000) Combinatorial mRNA regulation: iron regulatory proteins and iso-iron-responsive elements (Iso-IREs). Journal of Biological Chemistry 275: 40659–40662.
21. StysA, GalyB, StarzynskiRR, SmudaE, DrapierJC, et al. (2011) Iron regulatory protein 1 outcompetes iron regulatory protein 2 in regulating cellular iron homeostasis in response to nitric oxide. The Journal of biological chemistry 286: 22846–22854.
22. TaylorM, QuA, AndersonER, MatsubaraT, MartinA, et al. (2011) Hypoxia-inducible factor-2alpha mediates the adaptive increase of intestinal ferroportin during iron deficiency in mice. Gastroenterology 140: 2044–2055.
23. AmbrosV (2004) The functions of animal microRNAs. Nature 431: 350–355.
24. BartelDP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281–297.
25. MeisterG (2007) miRNAs get an early start on translational silencing. Cell 131: 25–28.
26. WuL, FanJ, BelascoJG (2006) MicroRNAs direct rapid deadenylation of mRNA. Proceedings of the National Academy of Sciences of the United States of America 103: 4034–4039.
27. LeungAK, SharpPA (2010) MicroRNA functions in stress responses. Molecular cell 40: 205–215.
28. CastoldiM, Vujic SpasicM, AltamuraS, ElmenJ, LindowM, et al. (2011) The liver-specific microRNA miR-122 controls systemic iron homeostasis in mice. The Journal of clinical investigation 121: 1386–1396.
29. KoellerDM, CaseyJL, HentzeMW, GerhardtEM, ChanLN, et al. (1989) A cytosolic protein binds to structural elements within the iron regulatory region of the transferrin receptor mRNA. Proceedings of the National Academy of Sciences of the United States of America 86: 3574–3578.
30. RouaultTA, HentzeMW, CaughmanSW, HarfordJB, KlausnerRD (1988) Binding of a cytosolic protein to the iron-responsive element of human ferritin messenger RNA. Science 241: 1207–1210.
31. BetelD, WilsonM, GabowA, MarksDS, SanderC (2008) The microRNA.org resource: targets and expression. Nucleic Acids Research 36: D149–153.
32. LewisBP, BurgeCB, BartelDP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15–20.
33. ChenCF, HeX, ArslanAD, MoYY, ReinholdWC, et al. (2011) Novel regulation of nuclear factor-YB by miR-485-3p affects the expression of DNA topoisomerase IIalpha and drug responsiveness. Mol Pharmacol 79: 735–741.
34. Muinos-GimenoM, GuidiM, KagerbauerB, Martin-SantosR, NavinesR, et al. (2009) Allele variants in functional MicroRNA target sites of the neurotrophin-3 receptor gene (NTRK3) as susceptibility factors for anxiety disorders. Hum Mutat 30: 1062–1071.
35. HutvagnerG, SimardMJ, MelloCC, ZamorePD (2004) Sequence-specific inhibition of small RNA function. PLoS Biol 2: e98 doi:10.1371/journal.pbio.0020098.
36. NielsenCB, ShomronN, SandbergR, HornsteinE, KitzmanJ, et al. (2007) Determinants of targeting by endogenous and exogenous microRNAs and siRNAs. RNA 13: 1894–1910.
37. DonovanA, LimaCA, PinkusJL, PinkusGS, ZonLI, et al. (2005) The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab 1: 191–200.
38. ZhangDL, HughesRM, Ollivierre-WilsonH, GhoshMC, RouaultTA (2009) A ferroportin transcript that lacks an iron-responsive element enables duodenal and erythroid precursor cells to evade translational repression. Cell Metabolism 9: 461–473.
39. De DomenicoI, LoE, YangB, KorolnekT, HamzaI, et al. (2011) The role of ubiquitination in hepcidin-independent and hepcidin-dependent degradation of ferroportin. Cell Metabolism 14: 635–646.
40. TongWH, RouaultTA (2006) Functions of mitochondrial ISCU and cytosolic ISCU in mammalian iron-sulfur cluster biogenesis and iron homeostasis. Cell Metabolism 3: 199–210.
41. ChanSY, ZhangYY, HemannC, MahoneyCE, ZweierJL, et al. (2009) MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2. Cell Metabolism 10: 273–284.
42. CianettiL, SegnaliniP, CalzolariA, MorsilliO, FelicettiF, et al. (2005) Expression of alternative transcripts of ferroportin-1 during human erythroid differentiation. Haematologica 90: 1595–1606.
43. ZhangDL, HughesRM, Ollivierre-WilsonH, GhoshMC, RouaultTA (2009) A ferroportin transcript that lacks an iron-responsive element enables duodenal and erythroid precursor cells to evade translational repression. Cell Metab 9: 461–473.
44. HafnerM, LandthalerM, BurgerL, KhorshidM, HausserJ, et al. (2010) Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell 141: 129–141.
45. ChiSW, ZangJB, MeleA, DarnellRB (2009) Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature 460: 479–486.
46. KeeneJD (2007) RNA regulons: coordination of post-transcriptional events. Nature Reviews Genetics 8: 533–543.
47. TenenbaumSA, ChristiansenJ, NielsenH (2011) The post-transcriptional operon. Methods in Molecular Biology 703: 237–245.
48. KotaJ, ChivukulaRR, O'DonnellKA, WentzelEA, MontgomeryCL, et al. (2009) Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 137: 1005–1017.
49. TakeshitaF, PatrawalaL, OsakiM, TakahashiRU, YamamotoY, et al. (2010) Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes. Molecular therapy : the journal of the American Society of Gene Therapy 18: 181–187.
50. WigginsJF, RuffinoL, KelnarK, OmotolaM, PatrawalaL, et al. (2010) Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34. Cancer research 70: 5923–5930.
51. ElmenJ, LindowM, SchutzS, LawrenceM, PetriA, et al. (2008) LNA-mediated microRNA silencing in non-human primates. Nature 452: 896–899.
52. LanfordRE, Hildebrandt-EriksenES, PetriA, PerssonR, LindowM, et al. (2010) Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 327: 198–201.
53. ChlostaS, FishmanDS, HarringtonL, JohnsonEE, KnutsonMD, et al. (2006) The iron efflux protein ferroportin regulates the intracellular growth of Salmonella enterica. Infection and immunity 74: 3065–3067.
54. NairzM, TheurlI, LudwiczekS, TheurlM, MairSM, et al. (2007) The co-ordinated regulation of iron homeostasis in murine macrophages limits the availability of iron for intracellular Salmonella typhimurium. Cellular microbiology 9: 2126–2140.
55. SangokoyaC, TelenMJ, ChiJT (2010) microRNA miR-144 modulates oxidative stress tolerance and associates with anemia severity in sickle cell disease. Blood 116: 4338–4348.